Skip to main content
Fig. 2 | Clinical Proteomics

Fig. 2

From: Proteomic and phosphoproteomic measurements enhance ability to predict ex vivo drug response in AML

Fig. 2

Linear modeling description and performance. A Summary of drug response values across 26 drugs and 31 patient samples together with the data available for each patient sample (across top). B Cross-validation performance of Elastic Net, LASSO, and Logistic regression with various types of data or combinations of data types. Performance is measured by Spearman correlation with held out dataset

Back to article page